BioNTech

BioNTech 是一家在股票代码 BNTX (DE) 下上市的公司。

BioNTech 在 3 个国家有直接业务。

BioNTech 拥有 3家子公司，其中包括 BioNTech IMFS、BioNTech US 和 InstaDeep。

他们在：

• 生物技术75%
• 软件25%

涉及BioNTech的并购和融资。

• BioNTech 刚刚宣布为 145 筹款数百万美元。 (公布2024六月5号).
• BioNTech 已收购 InstaDeep (公布2023八月1号).
• BioNTech has announced the acquisition of InstaDeep  (公布2023一月12号).

查看带有其 50 名主要高管的组织结构图

BioNTech 搜索最多的简介

• Ugur Sahin, Chief Executive Officer
• Ulrich Wandschneider, Director
• Michael Motschmann, Director

高管在BioNTech变化

• Annemarie HanekampAnnemarie Hanekamp 将于20247月1作为 Chief Commercial Officer 加入公司  (新闻发布的2024三月21号).
• Sean Marett, Chief Business Officer and Chief Commercial Officer, 将于 20243月31 退休  (新闻发布的2024三月11号).
• James Ryan 曾任 Chief Legal Officer, 将于 20243月31 升职为 Chief Legal Officer and Chief Business Officer  (新闻发布的2024三月11号).

创建提醒
跟踪 BioNTech 的高管变动

BioNTech 拥有 2,326 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。

Popular M&A news in 生物技术

• TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).
• Trace Neuroscience 刚刚宣布为 101 筹款数百万美元。 (公布2024十一月14号).
• AvenCell Therapeutics 刚刚宣布为 112 筹款数百万美元。 (公布2024十一月11号).

生物技术 行业的其他推荐联系人

• Scholar Rock 企业 Kristina Burow - Director
• UroGen 企业 Fred Cohen - Director
• Adaptimmune Therapeutics 企业 Ali Behbahani - Non-Executive Director

了解更多有关生物技术行业的信息 >

BioNTech 的最新新闻稿

• Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design | BioNTech
• BioNTech to Report Second Quarter 2022 Financial Results and Operational Update on August 8, 2022 | BioNTech
• Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.1 Adapted Bivalent Vaccine Candidate | BioNTech
• Pfizer and BioNTech Submit a Variation to EMA for the Vaccination of Children Ages 6 Months to less than 5 Years with COMIRNATY® | BioNTech
• Pfizer and BioNTech Announce U.S. FDA Approval of their COVID-19 Vaccine COMIRNATY® For Adolescents 12 through 15 Years of Age | BioNTech
• Statement on Patent Infringement Lawsuit in Germany | BioNTech
• Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine | BioNTech
• Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron | BioNTech
• BioNTech Receives Priority Medicines (PRIME) Designation from EMA for Enhanced Regulatory Support of CAR-T Candidate BNT211 in Testicular Cancer | BioNTech
• BioNTech Starts Construction of First mRNA Vaccine Manufacturing Facility in Africa | BioNTech
• View more press releases Close

关于 BioNTech 的社交媒体

• BioNTech 在 维基百科、谷歌新闻 和 雅虎财经
• BioNTech 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Ugur Sahin

致电BioNTech，电话：+49 61...

查看组织结构图

Register to receive your alert

报告错误